Assessing the risk of vaccine-driven virulence evolution in SARS-CoV-2
View ORCID ProfileIan F. Miller, View ORCID ProfileC. Jessica E. Metcalf
doi: https://doi.org/10.1101/2020.12.01.20241836
Ian F. Miller
1Department of Ecology and Evolutionary Biology, Princeton University
C. Jessica E. Metcalf
1Department of Ecology and Evolutionary Biology, Princeton University
2Princeton School of Public and International Affairs
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted June 11, 2021.
Assessing the risk of vaccine-driven virulence evolution in SARS-CoV-2
Ian F. Miller, C. Jessica E. Metcalf
medRxiv 2020.12.01.20241836; doi: https://doi.org/10.1101/2020.12.01.20241836
Subject Area
Subject Areas
- Addiction Medicine (326)
- Allergy and Immunology (642)
- Anesthesia (170)
- Cardiovascular Medicine (2452)
- Dermatology (208)
- Emergency Medicine (384)
- Epidemiology (11896)
- Forensic Medicine (10)
- Gastroenterology (707)
- Genetic and Genomic Medicine (3828)
- Geriatric Medicine (356)
- Health Economics (646)
- Health Informatics (2470)
- Health Policy (954)
- Hematology (348)
- HIV/AIDS (806)
- Medical Education (379)
- Medical Ethics (105)
- Nephrology (409)
- Neurology (3595)
- Nursing (202)
- Nutrition (536)
- Oncology (1865)
- Ophthalmology (544)
- Orthopedics (227)
- Otolaryngology (293)
- Pain Medicine (235)
- Palliative Medicine (68)
- Pathology (457)
- Pediatrics (1057)
- Primary Care Research (432)
- Public and Global Health (6259)
- Radiology and Imaging (1317)
- Respiratory Medicine (842)
- Rheumatology (387)
- Sports Medicine (332)
- Surgery (418)
- Toxicology (51)
- Transplantation (177)
- Urology (149)